Table 3

Malignant lesions and participation in populations at elevated risk of advanced melanoma

Men older than 50Othersp Value>60 years old<60 years oldp Value
% (n/N)% (n/N)% (n/N)% (n/N)
Proportion of included patients who attended the GP consultation66.0 (281/426)52.4 (1740/3319)<0.00172.4 (516/713)49.6 (1505/3032)<0.001
Proportion of patients referred to a dermatologist11.4 (32/281)12.4 (215/1740)0.7210.7 (55/516)12.8 (192/1505)0.24
Proportion of referred patients who actually consulted the dermatologist87.5 (27/32)66.5 (143/215)0.06770.9 (39/55)68.2 (131/192)0.83
Proportion of patients lost to follow-up10.0 (43/430)18.0 (522/2900)<0.0018.0 (62/775)19.0 (603/3174)<0.001
Proportion of overall patients who had a dermatological skin examination19.0 (81/426)16.1 (535/3319)0.1517.7 (126/713)16.2 (490/3032)0.36
Proportion of exeresis decision after dermatologist consultation21.0 (17/81)11.6 (62/535)0.02915.9 (20/126)12.0 (59/490)0.32
Proportion of malignant lesions among excised lesions66.7 (12/18)21.5 (14/65)<0.00166.7 (14/21)19.4 (12/62)<0.001
Crude incidence of melanoma469/105120/1050.14420/10599/1050.09